Figure 5 reports the circulating concentrations of IL-6 and IL-8 (panels A and B, respectively) and the serum levels of TNF- α (panel C) and IL-10 (panel D) in patients with obesity before and after eight weeks of the VLCKD. Here, IL6 is linked to obesity disorder.